Phase 4 Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 90 years old who have been diagnosed with ATTR-CM (a heart condition caused by a protein called transthyretin building up in the heart), or who carry the gene associated with this condition, confirmed at the Second Affiliated Hospital of Zhejiang University School of Medicine — any gender is eligible
- People who are able to understand what the trial involves and can work cooperatively with the research team
Who may not be able to join:
- People who are unable to understand the consent forms, are unwilling to sign them, or are unwilling to attend follow-up visits as required by the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of cardiovascular death, myocardial infarction, and stroke
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.